Form D · Other Health Care

Aimmune Therapeutics, Inc.

Brisbane, CA · CIK 0001631650

Offering snapshot reported Nov 29, 2018 · SEC filing

Reported sold
$98M
Offering amount: $98M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 28, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 29, 2018Initial$98,000,002No comparison1SEC filing
Mar 16, 2018Initial$156,700,012No comparison2SEC filing
Mar 24, 2015Initial$80,000,002No comparison10SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-326810

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
n/aNone

Source: Form D, filed Nov 29, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Daniel C. Adelman Executive
Susan E. Barrowcliffe Executive
Gregory Behar Director
Eric H. Bjerkholt Executive
Victor Colunga Executive
Jayson D.A. Dallas Director, Executive
Stephen G. Dilly, Jr. Director, Executive
Patrick G. Enright Director
Kathryn E. Falberg Director
Brett K. Haumann Director
Mark T. Iwicki Director
Jeffrey H. Knapp Executive
Mark D. Mc Dade Director
Mary M. Rozenman Executive
Stacey D. Seltzer Director
Douglas T. Sheehy Executive
James Tananbaum Director
Bryan L. Walser Director
Joonkyoo (Anthony) Yun Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
8000 Marina Boulevard Suite 300
Brisbane, CA, 94005-1884